Radiotherapy and Long-term Outcomes in Early Breast Cancer With SLNB Omission | MicrobiomeTrials← Back to trialsNCT07803081
Radiotherapy and Long-term Outcomes in Early Breast Cancer With SLNB Omission
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-08-06Est. Completion: 2036-08-05
Enrollment target: 500 participants Locations- Samsung Medical Center, Seoul, South Korea
Other microbiome trials you might be interested in
Hormone Receptor-Positive Breast CancerHER2 Low Breast CarcinomaEarly-Stage Breast Cancer
This is a single-center, open-label, randomized phase II clinical trial designed to evaluate the efficacy and safety of …
Guangzhou, ChinaEst. completion Sep 15, 2028
Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIC Breast Cancer AJCC v8
Estrogen Receptor-Positive Breast Carcinoma
HER2-Negative Breast Carcinoma
This phase III trial compares standard of care hormone therapy plus ribociclib to chemotherapy followed by hormone thera…
Jonesboro, United StatesEst. completion Jul 31, 2029
Breast Cancer
This is a multi-institutional pilot trial for patients with advanced breast cancer. The trial is designed to assess the …
Washington D.C., United StatesEst. completion Apr 2027